Health Condition 1: J309- Allergic rhinitis, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Already diagnosed case of allergic rhinitis 2) Patients with Symptoms of Allergic rhinitis (AR) such as nasal discharge, sneezing, nasal congestion, nasal itching supported by elevated Serum Total IgE level (more than 200 IU/ml) 3) Patients of both sexes: age 13-60 years. 4) Patient already undergoing conventional treatment for allergic rhinitis may be recruited after a washout period of 1 month. 5) Patient willing to give informed consent and patitent of age between 13-17 years willing to give Assent and Parent consent to participate in the study
Exclusion criteria
Exclusion criteria: 1) Case of nasal development defect or structural abnormalities nasal polyp, deviated nasal septum 2) Patient having severe co-morbidities of allergic rhinitis like asthma, sinusitis, etc 3) Critically ill patient. 4) Diagnosed case of mental or psychiatric illness 5) Patient with substance abuse 6) Pregnant and lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome is to assess the improvement in severity of nasal symptoms using TNSS - Total Nasal Symptom ScoreTimepoint: The outcome data will be collected at baseline and every four weeks up to six months. | — |
Secondary
| Measure | Time frame |
|---|---|
| i. To Assess the improvement in quality of life by Mini RQLQ Rhinoconjunctivitis Quality of Life Questionnaire.Timepoint: The outcome data will be collected at baseline and every four weeks up to six months.;ii. To Assess the change in Serum Total IgE levels measured at baseline and at six months post-intervention.Timepoint: The outcome data will be collected at the baseline and after six months in follow up sheets based on which data assessment will be done. | — |
Countries
India
Contacts
Mahesh Bhattacharyya Homoeopathic Medical College and Hospital